Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function

Schizophrenia Bulletin
Emanuel SchwarzAndreas Meyer-Lindenberg

Abstract

Schizophrenia is a severe and highly heritable psychiatric disorder affecting approximately 1% of the population. Genome-wide association studies have identified 108 independent genetic loci with genome-wide significance but their functional importance has yet to be elucidated. Here, we develop a novel strategy based on network analysis of protein-protein interactions (PPI) to infer biological function associated with variants most strongly linked to illness risk. We show that the schizophrenia loci are strongly linked to synaptic transmission (P FWE < .001) and ion transmembrane transport (P FWE = .03), but not to ontological categories previously found to be shared across psychiatric illnesses. We demonstrate that brain expression of risk-linked genes within the identified processes is strongly modulated during birth and identify a set of synaptic genes consistently changed across multiple brain regions of adult schizophrenia patients. These results suggest synaptic function as a developmentally determined schizophrenia process supported by the illness's most associated genetic variants and their PPI networks. The implicated genes may be valuable targets for mechanistic experiments and future drug development approaches.

References

Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Oct 15, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·L J GareySteven Hirsch
Feb 25, 1999·The New England Journal of Medicine·Preben B MortensenM Melbye
Sep 3, 1999·Biological Psychiatry·David A LewisT U Woo
Jan 13, 2000·Archives of General Psychiatry·L A Glantz, D A Lewis
Apr 28, 2000·The American Journal of Psychiatry·I M RossoT L Gasperoni
May 10, 2000·The Journal of Emergency Medicine·A L WeinerM J Bayer
Jul 13, 2000·Archives of General Psychiatry·T H McGlashan, R E Hoffman
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Guochuan Tsai, Joseph T Coyle
Jul 2, 2002·The American Journal of Psychiatry·Mary CannonRobin M Murray
Dec 10, 2003·Archives of General Psychiatry·Patrick F SullivanMichael C Neale
Apr 2, 2004·The American Journal of Psychiatry·James E BlackWilliam T Greenough
Jun 3, 2005·The American Journal of Psychiatry·Nutan KolluriDavid A Lewis
Dec 31, 2005·Nucleic Acids Research·Chris StarkMike Tyers
Jan 24, 2006·Biological Psychiatry·Klaas E StephanKarl J Friston
Apr 10, 2008·Nature Reviews. Genetics·Mark I McCarthyJoel N Hirschhorn
Jun 27, 2008·Annals of the New York Academy of Sciences·Ezra SusserLin He
Jul 19, 2008·Schizophrenia Bulletin·Vijay A MittalTyrone D Cannon
Sep 10, 2008·Brain Research·Sujatha NarayanElizabeth A Thomas
Dec 9, 2008·Nature Genetics·Sekar KathiresanL Adrienne Cupples
Apr 30, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ethan G HughesRita J Balice-Gordon
Aug 28, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Monica Beneyto, David A Lewis
Oct 26, 2010·Journal of Neurology·Michael S ZandiBelinda R Lennox
Dec 18, 2010·Lancet Neurology·Josep DalmauRita Balice-Gordon
May 4, 2011·Journal of Neuroscience Research·Michael R BarnesJackie de Belleroche
Oct 28, 2011·Nature·Hyo Jung KangNenad Sestan
Jan 4, 2012·Molecular Psychiatry·M MistryPaul Pavlidis
May 2, 2012·Neuroscience·J R Glausier, David A Lewis
Jun 14, 2012·PLoS Computational Biology·Nives SkuncaChristophe Dessimoz
Jul 11, 2012·Nature Reviews. Genetics·Patrick F SullivanMichael C O'Donovan
Nov 14, 2012·Molecular Psychiatry·C ChenC Liu
Jan 9, 2013·Bioinformatics·Jesse Gillis, Paul Pavlidis
Mar 5, 2013·Lancet·Cross-Disorder Group of the Psychiatric Genomics Consortium
Aug 27, 2013·Nature Genetics·Stephan RipkePatrick F Sullivan
Jan 28, 2014·Nature·Menachem FromerMichael C O'Donovan

Citations

Aug 3, 2018·Translational Psychiatry·Junfang ChenEmanuel Schwarz
Jun 5, 2019·Current Neuropharmacology·Pablo L CardozoFabíola M Ribeiro
Feb 6, 2018·Experimental and Therapeutic Medicine·Lu ChengJing Wang

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here